Indian pharma Inc On the move
The Indian pharmaceutical sector is currently undergoing unprecedented changes. This can be attributed largely to the country's introduction of product patents on January 1st, 2005.
New Patent Regime: Changing for the better
.India is the 4th largest economy of the world in terms of Purchasing Power Parity with only USA, China and Japan ahead of it and Germany occupying the fifth place.
Time to take up fresh challenges
India today has the largest number of US Food & Drug Administration (FDA) approved drug manufacturing facilities outside the US.
Dr Kaiser Waheed new chairman of Pharmaceutical Manufacturers Association of Pakistan
Dr. Kaiser Waheed, chairman and managing director of Medisure Laboratories Private Limited, Karachi, has been elected as the chairman of the Pharmaceutical Manufactu-rers Association (PMA) of Pakistan
Higher earnings for homegrown firms
The Indian pharmaceutical segment is going ahead strongly with huge investment in expansion, R&D, aggressive marketing and mergers and acquisitions.
Banking on R&D for future growth
The Indian pharmaceutical industry has been aggressive in the R&D front especially during the last couple of years,
Overseas trade edges up
The stiff price competition in international generic market, stringent approval norms of regulatory authorities, reduction in budget for healthcare by several governments, enhanced mergers and acquisitions activities
MNCs improve bottom lines
The net sales of ten MNCs viz., increased only by 9.4 per cent to Rs 5,046 crore during the year 2005-06 from Rs 4,612 crore in the previous year.
Pharma scrips withstand market swings
The secondary market in India exhibited volatile price movements so far in the year 2006. Almost all sectors went through sharp ups and downs.
More mid-caps in IPO fray
The Initial Public Offer of Amar Remedies Ltd of 150 lakh equity shares was oversubscribed by 2.15 times on August 29, 2005.
Acquisition spree, R&D strain returns
The pharmaceutical segment worldwide is passing through challenging situation. The generic competition is increasing day by day with rising number of off-patent drugs
Data exclusivity - a practical model for India
Post WTO-TRIPs compliance, Indian pharma industry's wish-list would naturally have been dominated by a data exclusivity free regime
Indian firms foray European generics market
Generics are creating their presence in the marketplace and increasingly gaining traction over branded pharmaceuticals, despite signs showing an imminent slowdown in growth as fewer drugs come off patent
Samples solutions from Prabha Engineering Products
A Sampler is a very important instrument in the manufacturing process in various industries. It is not the equipment to be neglected and carelessly selected
Spence Strainers International announces FM approved Double Door Check Valves
Spence Strainers International, of Walden, NY, announces FM (Factory Mutual) approval of their Model 125WT, ASME Class 125, cast iron, double door check valves in size 2 inch through 10 inch.
Loba Chemie - aiming European markets
The ISO certified Loba Chemie is one of the leading companies in the field of organic/inorganic fine chemicals & laboratory reagents in India
New patent regime spurs need to innovate
The more things change, the more they remain the same. In the context of the product patent regime, which became law in India in April 2005,
India rings in new era issuing product patents
India's transition towards a product patent regime as required under World Trade Organization (WTO) agreements became complete with the third amendment of the Patent Act last year
Data exclusivity soon
The long standing demand of multinational pharmaceutical companies for 'protection' of the test data given for regulatory approval from the generic manufacturer seems to be fulfilled soon.
Poised to take a big leap
The Indian pharmaceutical market currently stands at $6 billion and is growing at a steady rate of 10-15%. About 60% from exports to about 65 countries.
India to outsource 15% of global bulk drug by 2010
India was estimated to account for around seven per cent of the global outsourcing market for bulk drugs in 2004. By 2009-10, India is expected to grab 10-15 per cent share of the global bulk drug outsourcing market.
Outsourcing: An opportunity first and challenge next
Globalization has not merely broken boundaries. It has also broken the mental block amongst the pharmaceutical manufacturers in the developed countries.
Clinical research industry is growing exponentially in the past few years. It has opened large number of career opportunities to medical, pharma and all interdisciplinary fields.
Huge opportunities for global investors
In the modern day era clinical trials are the cornerstone of drug discoveries as only studies on human volunteers can prove the safety and efficacy of a new drug or procedure.
Quicker enrolling, low cost make India attractive hub
India is rapidly becoming clinical research hub in the world which is evident by the opening up of the Indian market to multinational pharmaceutical companies for conducting clinical
Human resource - a growing need
Contract research organization (CRO) is one that manages a research or an investigation to assess and / or verify the clinical, pharmacological or other pharmacodynamic effects,
Towards a different model in partnering
Many organizations are turning to research process outsourcing (RPO) to respond to increasing cost structures, drive top-line revenues and look for rapid and effective ways to get access to cutting-edge technology without huge capital outlays.
CRAMS business scales new highs
Pharmaceutical industry is undergoing a radical transformation globally due to increased pressures on profit margins, absence of blockbuster molecules, spiraling R&D costs,
More than just cost saving
Indian pharmaceutical companies are well positioned to generate good quality and high value products for global pharma players by taking on contract manufacture work.
Indian custom manufacturers will gain market share over global players soon"
With a vision to set a firm foot-hold as an end-to-end service provider in the custom manufacturing space across Asia, Europe and North America
Granules pitches on high margin PFIs
The Hyderabad-based Granules India is targeting regulated markets in the US and Europe in the pharmaceutical formulation intermediates (PFIs) segment.
Emergence of small-timers to the big league
The Small and Medium scale Entrepreneurs in India are more in a transition mode, with high prospects based on the true stories of Indian small scale companies
Machinery solutions from Anish Pharma
The company was accredited with ISO-9001 in 1994 and from AQA ( American Quality Assessors ) in 1999
Metrochem eyes contract mfg opportunities
Metrochem API Private Limited is an ISO-9001: 2000 and cGMP certified vertically integrated Active Pharmaceutical Ingredients (APIs), API Pellets and Intermediates for APIs manufacturing company based at Hyderabad, A.P. India.
Intermediates of the future
Organic fluorointermediates are gaining a lot of importance in the Indian and global chemical and pharmaceutical industry and research & development
Medical tourism heading for a boom
Medical Tourism in India has a potential of growing by a massive 25 percent annually to generate Rs.100 billion ($2.15 billion) a year by 2012. To capitalize the opportunity,
Biodiversity: Treasure trove of resources
Twentieth century witnessed a paradigm shift in the driving force of the world from the traditional military power to the industrial and financial powers. 21st century we are witnessing yet with another revolutionary driving force
Centre announces guidelines toregulate naturopathy
In a first of its kind initiative, the Department of Ayush under the Ministry of Health and Family Welfare has announced basic guidelines to be followed by various states for the registration of Naturopathy
Move to tap potential of ISMs in HIV/AIDS cure
Soon India will come out with a defined research agenda, in collaboration with international research institutes, to tap the potential of Indian traditional medicines in the area of HIV/AIDS cure.
Traditional medicine:Waiting to be tapped to the full
Traditional medicines have always maintained their popularity worldwide. They are in widespread use throughout the world.
TKDL - comprehensive data on Indian Systems of Medicine
The Traditional Knowledge Digital Library (TKDL) project, initiated by the Indian Government to protect the interests of Indian Systems of Medicine (ISM),
Contemporary prerogatives in herbal research
Among the many traditional health care streams of the world, Ayurveda is unique in its sound foundation of documented theories and operational guides
Ayurveda - the Vedic science of longevity
Ayurveda means literally the 'science (Veda) of longevity'; because of its divine origins it can be called 'Medicine of the Gods'.
Major Procedures in Ayurveda
The major procedures which are performed in the Ayurvedic treatments are discussed in detail below:
Siddha: Treating three humours
Siddha system of medicine and treatment is popular in South India, especially widely followed by the peopleof Tamil Nadu formany centuries.
Aiming to be among world's Top Five
India is making efforts to gear up to be among the top five global biotech nations in the world. In the Asia-Pacific region, Australia conquered the top slot, followed by India and China. It is not difficult for India to emerge
National biotech strategy to promote growth
The National Biotechnology Development Strategy of India aims at creating such tools and technologies that address the problems of the largest section of the society,
Waiting on the wings
India's Lifescience industry is moving to innovation led research and products. Consequently, the information emerging out of biotechnology research is increasing at a rapid pace
Private equity in lifesciences to grow
Private equity investments scenario in life sciences is tend to change gradually. Biotechnology is showing enormous growth in the last few years. Globally, biotech companies
Avesthagen: Pathbreaking technologies
Avestha Gengraine Technologies Pvt. Ltd (Avesthagen), the drug discovery-driven life sciences company has received the Red Herring 100 Asia Winner 2006 for disruptive technology.
Innovators in developing world
For many years, R&D initiatives and operations have been the privilege of the developed countries, Europe, USA and Japan remaining the major innovators
Fragment based strategy gaining ground
Pharmaceutical industry is facing a key challenge in terms of declining pipelines of NCEs despite exponential increase in R&D spending and breakthroughs achieved in several technological fronts
AstraZeneca's $40m 'war' on TB
An estimated two billion people around the world and two million in India suffer from tuberculosis. There is treatment but there is no single drug as yet; and for over 40 years,
EDAL to launch Alu/Alu packs
Ess Dee Aluminium Ltd (EDAL), engaged in producing specialised pharmaceutical packaging, will soon introduce Alu/Alu packaging and child resistant packaging solutions.
Demand for devices to peak
Why India is becoming one of the major source points for lab equipment?
a) For knowledge-intensive industries such as those described earlier, India has a good pool of scientific talent available at a very low cost.
India Shining was the slogan used by the NDA front in the last general elections. They failed miserably in the elections, despite the catchy slogan and a good advertising campaign.
Why 58th Indian Pharmaceutical Congress is going to be different?
The first IPC I ever attended was sometime in the early '70s; I was new to 'Pharmaceutical India' having returned from the UK after my studies. The IPC was in Bhubaneshwar
A French window to EU Pharma
Europe has become the new passion for Indian drug makers, these days. Not only to Indian firms, but the generic drug companies
CPhI Worldwide 2005 - A recap
Launched in 1990 as an international convention on pharmaceutical ingredients and intermediates, CPhI is the leading exhibition on pharmaceutical ingredients and allied industries.
New guidelines on anvil for medical devices
There has been considerable discussion about the rapid growth of the biopharmaceutical industry in India, but an understated fact is that the increasing competition is also driving industry to become increasingly compliant
Copyright © Saffron Media Pvt. Ltd.